Gemfibrozil as a Lipid Lowering Compound in Hyperlipoproteinæmia. A Placebo-controlled Cross-over Trial

Beaumont J L , Carlson L A , Cooper G R , Fejfar Z , Fredrickson D S , & Strasser T (1970) Bulletin of the World Health Organization 43, 891

Burstein M , & Samaille J (1960) Clinica Chimica Acta 5, 609

Carlson L A , Olsson A G , Orö L , Rössner S , & Walldius G (1974) In: Atherosclerosis 3. Ed. Schettler G , & Weizel A . Springer, Berlin &c.; p 768

Fredrickson D S , Levy R I , & Lees R S (1967) New England Journal of Medicine 276, 33, 94, 148, 215, 273

Gustafson A (1975) Postgraduate Medical Journal 51, Suppl. 8, 66

Havel R J , Eder H A , & Bragdon J H (1955) Journal of Clinical Investigation 34, 1345

Ikkos D , & Luft R (1957) Acta Endocrinologica (Copenhagen) 25, 312

Lithell H , Boberg J , Hedstrand H , Hellsing K , Ljunghall S , & Vessby B (1976) (in press)

Lizana J , & Hellsing K (1974) Clinical Chemistry 20, 1181

Marks V , Frizel D , Twycross R G , & Buchanan K D (1971) In: Metabolic Effects of Nicotinic Acid and its Derivatives. Ed. Gey K F , and Carlson L A . Huber, Bern; p 961

Miller G J , & Miller N E (1975) Lancet i, 16

Noble R P (1968) Journal of Lipid Research 9, 693

Rush R L , Leon L , & Turrell J (1971) Advances in Automated Analysis 1, 503

Velasco C A , Cole H S , & Camerini-Davolos R A (1974) Clinical Chemistry 20, 700